Pilot-Scale Treatment of Neutral Pharmaceuticals in Municipal Wastewater Using Reverse Osmosis and Ozonation
Jordan Hollman, Muhammad Faizan Khan, John Albino Dominic, Gopal Achari
Abstract
Pharmaceutically active compounds (PhACs) reaching surface waters through municipal wastewater are a concern, as existing treatment processes poorly remove them. While significant lab-scale evaluations have been performed on treatment options, full-scale tests are lacking. Presented is an experimental study from a full-scale research facility that is imbedded in a functioning municipal wastewater plant. Reverse osmosis and ozonation were tested as part of an active treatment train using secondary treated effluent from the adjoining facility. Reverse osmosis removed 92.6%, 99.0%, 99.6%, 97.8%, 99.0%, 99.6%, 99.9%, and 99.2% of metformin, cotinine, trimethoprim, caffeine, venlafaxine, carbamazepine, erythromycin, and fluoxetine, respectively. By ozone, sulfamethoxazole, carbamazepine, erythromycin and o-desmethylvenlafaxine were removed by more than 99.9%. Trimethoprim and venlafaxine were removed by more than 95%, with the remaining compounds removed by between 16% and 85%. Results demonstrate the effectiveness of reverse osmosis and ozonation for full-scale treatment.